Myelodysplastic syndromes trials in France

In France 50 Also abroad 369

50 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 15 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
Biological, Prospective Study Evaluating the Dosage of Plasma Cytokines Including the FLT3 Ligand and IL6 of Patients Treated With Non-intensive Chemotherapy
Where
Nantes
Age
18 years to 99 years
People
60
Run by
Nantes University Hospital
See details and how to joinNCT06439199
Phase 3Taking people
Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation
Where
Nantes, Nice, Paris, Pessac, Toulouse Cedex 9, Vandoeuvre Les Nancy Cedex
Age
18 years and over
People
48 worldwide
Run by
Institut de Recherches Internationales Servier
See details and how to joinNCT06465953 · EU 2023-510155-37-00
Phase 2Taking people
Momelotinib in VEXAS Syndrome
Where
Angers, Clermont-Ferrand, Lille, Nantes, Paris, Pessac, Pierre-Bénite, Rennes, Toulouse, Tours
Age
18 years and over
People
57
Run by
Groupe Francophone des Myelodysplasies
See details and how to joinNCT07098936
Phase 2Enrolling by invitation
A Study for Participants Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose)
Where
Mulhouse
Age
18 years and over
People
332 worldwide
Run by
Taiho Oncology, Inc.
See details and how to joinNCT04093570 · EU 2024-516293-29-01
Phase 1/2Not yet taking people in France
A Study to Evaluate S241656 Alone or in Combination in Participants With Selected Myeloid Malignancies
Where
Marseille, Nice, Paris, Pessac Cedex, Villejuif
Age
18 years and over
People
64 worldwide
Run by
Servier
See details and how to joinNCT07719348 · EU 2025-525128-88-00
Phase 3Completed
A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
Where
Angers, Créteil, La Tronche, Lille, Marseille, Paris, Pessac, Pierre-Bénite, Strasbourg, Toulouse, Tours
Age
18 years and over
People
665 worldwide
Run by
Celgene
See details and how to joinNCT04064060
No phaseTaking people
Biocollection in MyeloDysplastic Syndrome (P-MDS)
Where
Brest
Age
18 years and over
People
150
Run by
University Hospital, Brest
See details and how to joinNCT04869683
Phase 1/2Completed
Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
Where
Bordeaux, Villejuif
Age
18 years and over
People
250 worldwide
Run by
CellCentric Ltd.
See details and how to joinNCT04068597
No phaseNot yet taking people in France
Study of NK Cells in the Monitoring of Patients With Acute Leukemia or Myelodysplasia
Where
Nantes
Age
18 years and over
People
55
Run by
Nantes University Hospital
See details and how to joinNCT07249476
Phase 1Taking people
Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutation
Where
Marseille, Pessac, Pierre-Bénite, Villejuif
Age
18 years and over
People
291 worldwide
Run by
Institut de Recherches Internationales Servier
See details and how to joinNCT02074839
Phase 2Taking people
A Study of Momelotinib in Participants With Low-risk Myelodysplastic Syndrome
Where
Le Mans Cedex 9, Nice, Paris, Poitiers, Toulouse Cedex 9
Age
18 years and over
People
80 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT06847867 · EU 2024-519928-24-00
No phaseTaking people
Contribution of Anti-platelet Antibodies Identified With MAIPA Assay in the Demonstration of the Auto-immune Character of a Thrombocytopenia at Diagnosis
Where
Pessac
Age
18 years and over
People
225
Run by
University Hospital, Bordeaux
See details and how to joinNCT04800458
No phaseTaking people
Creation of a Biocollection of Patients With Acute Myeloid Leukemia (AML) or Lymphoid Leukemia (ALL) or High-risk Myelodysplastic Syndrome (MDS) Monitored at the Nantes University Hospital
Where
Nantes
Age
18 years and over
People
1,000
Run by
Nantes University Hospital
See details and how to joinNCT06681363
Phase 1Taking people
CLADRIBINE DOSE ESCALATION IN CONDITIONING REGIMEN PRIOR TO ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (Allo-HSCT) FOR REFRACTORY ACUTE LEUKEMIA AND MYELODYSPLASTIC SYNDROMES
Where
Marseille
Age
18 years and over
People
29
Run by
Institut Paoli Calmettes
See details and how to joinNCT03235973 · EU 2024-515737-14-00
Phase 1/2Taking people
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Where
Angers, Bobigny, Le Mans, Lille, Limoges, Lyon, Marseille, Nantes, Nice, Paris, Talence, Villejuif
Age
12 years and over
People
606 worldwide
Run by
Sumitomo Pharma America, Inc.
See details and how to joinNCT04988555
No phaseNot yet taking people in France
Clonal Hematopoiesis of Immunological Significance
Where
Paris
Age
18 years and over
People
5,000
Run by
Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT05969821
Phase 1Taking people
First-In-Human study evaluating the Safety of administration of ABD-3001 to Patients with Relapsed/Refractory Acute Myeloid Leukemia or High/Very-high Risk Myelodysplastic Syndromes
Where
Marseille, Montpellier Cedex 5, Nice, Paris, Pierre-Bénite
Age
18 years and over
People
61
Run by
Advanced Biodesign
See details and how to join2024-518813-24-00
No phaseTaking people
Study of Families With an Hemopathies Predisposition Related to the DDX41 Gene.
Where
Bordeaux, Limoges, Marseille, Montpellier, Toulouse
Age
18 years and over
People
910
Run by
Institut Claudius Regaud
See details and how to joinNCT06022016
Phase 1/2Suspended
AB8939 in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Where
Marseille
Age
18 years and over
People
78 worldwide
Run by
AB Science
See details and how to joinNCT05211570 · EU 2024-516641-39-00
No phaseTaking people
Characterization of the Mechanisms of Resistance to Azacitidine
Where
Antibes, Nice
Age
18 years and over
People
250 worldwide
Run by
Centre Hospitalier Universitaire de Nice
See details and how to joinNCT01210274
No phaseTaking people
Ferroptosis Study in SF3B1-mutant Myelodysplastic Syndromes (FerMDS)
Where
Pessac
Age
18 years and over
People
80
Run by
University Hospital, Bordeaux
See details and how to joinNCT05924074
Phase 1/2Taking people
First-in-human Study Aiming to Characterize the Safety, Tolerability, Pharmacokinetic and Preliminary Signs of Activity of ABD-3001 in Refractory or Relapsed AML and High Risk MDS Adult Patients
Where
Marseille, Paris, Pierre-Bénite
Age
18 years and over
People
36
Run by
Advanced BioDesign
See details and how to joinNCT05601726
No phaseTaking people
The Patient Cohort of the National Center for Precision Medicine in Leukemia
Where
Bobigny, Paris
People
3,000
Run by
Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT05326919
No phaseNot yet taking people in France
Role of BMP Pathway in MDS Progression
Where
Lyon
Age
20 years and over
People
60
Run by
Hospices Civils de Lyon
See details and how to joinNCT06175923
No phaseTaking people
Institut Paoli Calmettes Myelodysplastic Syndromes Database
Where
Marseille
Age
18 years and over
People
10,000
Run by
Institut Paoli-Calmettes
See details and how to joinNCT03275480